1. [Atomoxetine for treatment of children and adolescents with ADHD].
- Author
-
Resen K, Pagsberg AK, and Jörgens G
- Subjects
- Adolescent, Adrenergic Uptake Inhibitors adverse effects, Adrenergic Uptake Inhibitors pharmacology, Atomoxetine Hydrochloride adverse effects, Atomoxetine Hydrochloride pharmacology, Child, Humans, Adrenergic Uptake Inhibitors therapeutic use, Atomoxetine Hydrochloride therapeutic use, Attention Deficit Disorder with Hyperactivity drug therapy
- Abstract
Atomoxetine reduces ADHD symptoms in children and adolescents significantly and is indicated for ADHD with co-morbid anxiety, depression and tics or with an increased risk of abuse. Number needed to treat is 3.4-5. Common adverse effects are stomach pain, decreased appetite and somnolence. Serious adverse effects include increased vascular tone, decreased growth rate and increased suicidal behaviour. In most cases adverse effects are mild to moderate and transient. Since atomoxetine was launched in 2006, 117 cases of toxic exposures have been reported in Denmark.
- Published
- 2014